News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Adrian Lee: Altered estrogen disposition and immune signals in the TME of breast cancers in older women
Adrian Lee/LinkedIn
Nov 6, 2024, 11:20

Adrian Lee: Altered estrogen disposition and immune signals in the TME of breast cancers in older women

Adrian Lee, Professor at UPMC Hillman Cancer Center, shared on X:

“Out on bioRxiv our study by Neil Carleton and the Lee-Oesterreich lab/collaborators on altered estrogen disposition and immune/inflammatory signals in the TME of breast cancers in older women.”

Adrian Lee

Systemic and local chronic inflammation and hormone disposition promote a tumor-permissive environment for breast cancer in older women.

Authors: Neil Carleton, Sanghoon Lee, Ruxuan Li, Jian Zou, Daniel D Brown, Jagmohan Hooda, Alexander Chang, Rahul Kumar, Linda R Klei, Lora H Rigatti, Joseph Newsome, Dixcy Jaba Sheeba John Mary, Jennifer M Atkinson, Raymond E West III, Thomas D Nolin, Patrick J Oberly, Ziyu Huang, Donald Poirier, Emilia J Diego, Peter C Lucas, George Tseng, Michael T Lotze, Priscilla F McAuliffe, Ioannis K Zervantonakis, Steffi Oesterreich, Adrian V Lee

Adrian Lee

Adrian Lee Adrian V Lee Alexander Chang bioRxiv cancer Daniel D Brown Dixcy Jaba Sheeba John Mary Donald Poirier Emilia J Diego estrogen disposition George Tseng Ioannis K Zervantonakis Jagmohan Hooda Jennifer M Atkinson Jian Zou Joseph Newsome Lee-Oesterreich lab Linda R Klei Lora H Rigatti Michael T Lotze Neil Carleton OncoDaily Oncology Patrick J Oberly Peter C. Lucas Priscilla F McAuliffe Rahul Kumar Raymond E West III Ruxuan Li Sanghoon Lee Steffi Oesterreich Thomas D Nolin Ziyu Huang
Special Coverage
Blog
Dec 22, 2024, 05:15
Jemma Arakelyan: Collaboration plans between City University of Hong Kong and Shenzhen Hospital of Southern Medical University
Blog
Dec 22, 2024, 05:13
The Connell and O’Reilly Families Cell Manipulation Core Facility at Dana-Farber Cancer Institute
Blog
Dec 22, 2024, 05:05
Ruben Mesa: Excited to visit Atrium Health Levine Cancer Pineville
Blog
Dec 22, 2024, 05:02
Muhammad Umair Mushtaq: Are Stem Cell Transplants Safe for Myelofibrosis Patients Over 70?
Blog
Dec 22, 2024, 05:00
Elvina Almuradova: Being a part of Giuseppe Curigliano's team is an invaluable scientific milestone for me
Blog
Dec 22, 2024, 04:58
Summary slide for PFS in selected trials by IGHV status caveat for CLL by Nitin Jain
Insight
Dec 22, 2024, 04:53
Cancer survivors are growing in number - National Cancer Institute
Blog
Dec 22, 2024, 04:52
Registration is open for the ESMO Gastrointestinal Cancers Congress 2025
Blog
Dec 22, 2024, 04:49
Amalya Sargsyan: New ESO Rare Cancer Series podcast with Salvatore Provenzano
Insight
Dec 22, 2024, 04:47
Journal of Psychosocial Oncology Research and Practice: Vol. 6, Number 4 - IPOS
Science
Dec 22, 2024, 04:40
The prevalence of widespread guideline-discordant LDCT screening in a low-risk population by So Yeon Kim et al.
Blog
Dec 22, 2024, 04:38
The new Institute of Cancer Research spinout company Sentinal4D has been announced to the public